Should Investors Be Worried About Pfizer and BioNTech's Coronavirus Vaccine Rollout?

In this video from Motley Fool Live, recorded on Dec. 21, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss the launch of Pfizer (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) coronavirus vaccine. The rollout has been slower than expected, but the bigger concern might be the allergic reactions caused by the vaccine. The duo also discuss the mystery of additional doses in each vial.

Continue reading

Source Fool.com